Back to Screener

Healthcare

Mesoblast Limited(MEOBF)

Live Price

Offline

$1.55

+0.00% today

Window Change

-8.82%

Window

May 29, 2026 β†’ Jun 23, 2026

Market Cap
$2.05B
Revenue Growth
+191.4%
EPS Growth
+3.6%
Dividend Yield
0.0%
Sparse coverage

Historical coverage is still filling in

This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.

Coverage: 17 bars Β· May 29, 2026 β†’ Jun 23, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Mesoblast Limited (MEOBF) is a Healthcare stock with a market cap of $2.05B and listed on OTC. The stock last traded around $1.55 and down 8.8% across the available one-year price window (May 29, 2026 β†’ Jun 23, 2026). Baseline metrics include revenue growth of +191.4%, EPS growth of +3.6%, a dividend yield of 0.0%. What stands out right now is revenue +191.4%, EPS +3.6%, free cash flow -3.9% with operating margin -572.0% and ROIC -12.4%. Valuation already assumes a fairly strong business story at price/sales 131.3. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines MEOBF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

MEOBF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

MEOBF

β€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

MEOBF Max Drawdown

-8.82%

Trailing 1Y

SPY Max Drawdown

β€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for MEOBF and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

πŸ“… Next earningsSep 2, 2026
PeriodB/MEPSEPS Ξ”RevenueRev Ξ”Report
β€”
Sep 2, 26
TBD
β€”
Est -0.01
β€”
β€”
Est 75462.1B
β€”
Sep 2
β€”
Feb 26, 26
βœ—
-0.03
Est -0.02
-31.2%
51342.0B
Est 53064.6B
-3.3%
Feb 26
β€”
Aug 28, 25
βœ“
-0.02
Est -0.04
+43.0%
7021.0B
Est 30678.8B
-77.1%
Aug 28
β€”
Apr 30, 25
-0.02
Est β€”
β€”
7021.0B
Est 7481.1B
-6.2%
Apr 30
β€”
Feb 26, 25
βœ“
-0.02
Est -0.05
+57.2%
1578.0B
Est 7481.1B
-78.9%
Feb 26
β€”
Oct 30, 24
-0.02
Est β€”
β€”
1578.0B
Est β€”
β€”
Oct 30
β€”
Aug 29, 24
βœ“
-0.02
Est -0.04
+30.0%
1257.0B
Est 4096.0B
-69.3%
Aug 29
β€”
Mar 31, 24
-0.02
Est β€”
β€”
1257.0B
Est β€”
β€”
Mar 31
β€”
Feb 29, 24
βœ“
-0.02
Est -0.04
+55.2%
1694.0B
Est 3869.0B
-56.2%
Feb 29
β€”
Sep 30, 23
βœ“
-0.02
Est -0.02
+22.5%
1694.0B
Est 5600.0B
-69.8%
Sep 30
β€”
Jun 30, 23
βœ“
-0.02
Est -0.03
+16.0%
2139.0B
Est 2383.4B
-10.3%
Jun 30
β€”
Mar 31, 23
βœ“
-0.03
Est -0.03
+19.8%
1939.0B
Est 2139.6B
-9.4%
Mar 31
β€”
Dec 31, 22
βœ—
-0.03
Est -0.03
-19.7%
1980.0B
Est 2100.0B
-5.7%
Dec 31
β€”
Sep 30, 22
βœ“
-0.02
Est -0.03
+21.7%
1443.0B
Est 3466.7B
-58.4%
Sep 30
β€”
Jun 30, 22
βœ—
-0.03
Est -0.02
-69.8%
2224.0B
Est 7594.3B
-70.7%
Jun 30
β€”
Mar 31, 22
βœ—
-0.03
Est -0.03
-28.1%
2011.0B
Est 2100.0B
-4.2%
Mar 31
β€”
Dec 31, 21
βœ—
-0.04
Est -0.04
-3.8%
2382.0B
Est 3500.0B
-31.9%
Dec 31
β€”
Sep 30, 21
-0.03
Est β€”
β€”
3594.0B
Est β€”
β€”
Sep 30
β€”
Jun 30, 21
-0.03
Est β€”
β€”
1996.0B
Est β€”
β€”
Jun 30
β€”
Mar 31, 21
-0.04
Est β€”
β€”
1913.0B
Est β€”
β€”
Mar 31
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener